Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
REDUCE-IT: CV Outcomes With Icosapent Ethyl by Baseline LDL-C
Author(s): Deepak L Bhatt Added: 1 year ago
In this insightful interview, Dr Deepak Bhatt (Mount Sinai Hospital, US) joins us to discuss findings from a post-hoc analysis of the REDUCE-IT trial, examining how icosapent ethyl affects cardiovascular outcomes across different baseline LDL-C levels.The study included 8,175 statin-treated patients with elevated cardiovascular risk and triglyceride levels between 135-499mg/dL. All participants… View more

Prevention & Chronic Conditions
Non-invasive Coronary Functional Tests in ANOCA
Author(s): Nello Cambise , Angelo Giuseppe Marino , Fabio De Benedetto , et al Added: 2 months ago

Imaging & Diagnostics

Prevention & Chronic Conditions
30th Annual Meeting of the ISCP
Author(s): Andrés Álvarez , Diego Manuel de la Eranueva , Manuel Sánchez , et al Added: 4 days ago

Prevention & Chronic Conditions
30th Annual Meeting of the ISCP
Author(s): Adela Castro Garcia , Carmen de la Hoz Lopez-Collado , Maria Victoria Luis Valle , et al Added: 5 days ago

Prevention & Chronic Conditions

Heart Failure
30th Annual Meeting of the ISCP
Author(s): Maria Victoria Luis Valle , Adela Castro Garcia , Diego De la Eranueva Calvo , et al Added: 5 days ago

Prevention & Chronic Conditions

Guidelines & Statements
30th Annual Meeting of the ISCP
Author(s): Carmen de la Hoz Lopez-Collado , María Laura García , Victoria Luis , et al Added: 5 days ago

Prevention & Chronic Conditions

Heart Failure
The Coronary Microcirculation Re-explored
Author(s): Ahmed Elamin , Mustafa Abdimalik , Mohanad Abdelrahim , et al Added: 5 months ago

Prevention & Chronic Conditions
Updates on Chronic Coronary Syndrome
Author(s): Filippo Gurgoglione , Giampaolo Niccoli Added: 1 year ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Atorvastatin and Ezetimibe in Patients with Acute Coronary Syndrome
Author(s): Mohammed Sallam , Hossameldin Hassan , Derek Connolly , et al Added: 1 year ago

Prevention & Chronic Conditions

MI/ACS
Ez-PAVE: Lower LDL-C Target Reduces CV Events
Added: 3 days ago Source:  Radcliffe CVRM
Recent US guidelines have controversially recommended lowering the low-density lipoprotein cholesterol (LDL-C) target to <55 mg/dL for patients with established atherosclerotic cardiovascular disease (ASCVD).¹˒² The Ez-PAVE trial is the first randomised study to directly compare this intensive target with a conventional target of <70 mg/dL. The findings were published in The New England… View more

Cardiovascular Kidney Metabolic

Demographic